Low triiodothyronine serum levels as a predictor of poor prognosis in burn patients

Burns

Volumn 34, Issue 6, 2008, Pages 817-824

  Gangemi, Ezio Nicola ^a   Garino, Francesca ^b   Berchialla, Paola ^b   Martinese, Morena ^b   Arecco, Federico ^b   Orlandi, Fabio ^b   Stella, Maurizio ^a  

^a Traumatologic and Orthopaedic Hospital   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Burns; Euthyroid sick syndrome; Prognostic index; Triiodothyronine

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BURN PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; FEMALE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVOR; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BURNS; EUTHYROID SICK SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TRIIODOTHYRONINE;

EID: 47649115950     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2007.10.002     Document Type: Article

References (35)

1. Reiss W., Pearson E., and Artz C.P. The metabolic response to burns. J Clin Invest 35 (1956) 62-77
2. Van den Berghe G.H. The neuroendocrine stress response and modern intensive care: the concept revisited. Burns 25 (1999) 7-16
3. Tredget E.E., and Yu Y.M. The metabolic effects of thermal injury. World J Surg 16 (1992) 68-79
4. Becker R.A., Vaughan G.M., Ziegler M.G., Seraile L.G., Goldfarb I.W., Mansour E.H., et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 10 (1982) 870-875
5. Becker R.A., Vaughan G.M., Goodwin Jr. C.W., Ziegler M.G., Zitzka C.A., Mason Jr. A.D., et al. Interactions of thyroid hormones and catecholamines in severely burned patients. Rev Infect Dis 5 (1983) S908-S913
6. Scoscia E., Baglioni S., Eslami A., Iervasi G., Monti S., and Todisco T. Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol 151 (2004) 557-560
7. Borkowski J., Siemiatkowski A., Wolczynski S., Czaban S.L., and Jedynak M. Assessment of the release of thyroid hormones in septic shock-prognostic significance. Pol Merkuriusz Lek 18 (2005) 45-48
8. Hamilton M.A., Stevenson L.W., Luu M., and Walden J.A. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 16 (1990) 91-95
9. Ture M., Memis D., Kurt I., and Pamukcu Z. Predictive value of thyroid hormones on the first day in adult respiratory distress syndrome patients admitted to ICU: comparison with SOFA and APACHE II scores. Ann Saudi Med 25 (2005) 466-472
10. Slag M.F., Morley J.E., Elson M.K., Crowson T.W., Nuttall F.Q., and Shafer R.B. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245 (1981) 43-45
11. Schilling J.U., Zimmermann T., Albrecht S., Zwipp H., and Saeger H.D. Low T3 syndrome in multiple trauma patients-a phenomenon or important pathogenetic factor. Medizinische Klinik 3 (1999) 66-69
12. Ward L.S., and Maciel R.M. Predictive value of the measurement of iodothyronines in the prognosis of patients with severe nonthyroidal illness. Rev Assoc Med Bras 43 (1997) 114-118
13. Vexiau P., Perez-Castiglioni P., Socie G., Devergie A., Toubert M.E., Aractingi S., et al. The 'euthyroid sick syndrome': incidence, risk factors and prognostic value soon after allogeneic bone marrow transplantation. Br J Haematol 85 (1993) 778-782
14. Rink C., Siersleben U., Haerting J., Mende T., and Nilius R. Development of the low-T3-syndrome and prognosis assessment in patients with liver cirrhosis. Gastroenterol J 51 (1991) 138-141
15. Girvent M., Maestro S., Hernández R., Carajol I., Monné J., Sancho J.J., et al. Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery 123 (1998) 560-567
16. den Brinker M., Joosten K.F.M., Visser T.J., Hop W.C.J., de Rijke Y.B., Hazelzet J.A., et al. Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteins. J Clin Endocrinol Metab 90 (2005) 5613-5620
17. Iervasi G., Pingitore A., Landi P., Raciti M., Ripoli A., Scarlattina M., et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 107 (2003) 708-713
18. Peeters R.P., Wouters P.J., van Toor H., Kaptein E., Visser T.J., and Van den Berghe G. Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90 (2005) 4559-4565
19. Roi L., Flora J., Davis T., and Wolfe R. Two new burn severity indices. J Trauma 23 (1983) 1023-1029
20. Van den Berghe G., de Zegher F., and Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 41 (1994) 731-737
21. Schilling T., Grundling M., Strang C.M., Moritz K.U., Siegmund W., and Hachenberg T. Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients. Intensive Care Med 30 (2004) 1127-1133
22. De Groot L.J. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84 (1999) 151-164
23. Kakucska I., Romero L.I., Clark B.D., Rondeel J.M., Qi Y., Alex S., et al. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology 59 (1994) 129-137
24. van der Poll T., Romijn J.A., Wiersinga W.M., and Sauerwein H.P. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71 (1990) 1567-1572
25. Stouthard J.M., van der Poll T., Endert E., Bakker P.J., Veenhof C.H., Sauerwein H.P., et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 79 (1994) 1342-1346
26. LoPresti J.S., Eigen A., Kaptein E., Anderson K.P., Spencer C.A., and Nicoloff J.T. Alterations in 3,3′5′-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J Clin Invest 84 (1989) 1650-1656
27. Lim C.F., Docter R., Visser T.J., Krenning E.P., Bernard B., van Toor H., et al. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 76 (1993) 1165-1172
28. Chopra I.J., Teco G.N., Nguyen A.H., and Solomon D.H. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses. J Clin Endocrinol Metab 49 (1979) 63-69
29. Chopra I.J. Euthyroid sick syndrome: is it a misnomer?. J Clin Endocrinol Metab 82 (1997) 329-334
30. Bacci V., Schussler G.C., and Kaplan T.B. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab 54 (1982) 1229-1235
31. Van den Berghe G., de Zegher F., and Lauwers P. Dopamine suppresses pituitary function in infants and children. Crit Care Med 22 (1994) 1747-1753
32. Fabris N., Mocchegiani E., and Provinciali M. Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine-immune interaction. Horm Res 43 (1995) 29-38
33. Van den Berghe G., de Zegher F., Vlasselaers D., Schetz M., Verwaest C., Ferdinande P., et al. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. Crit Care Med 24 (1996) 590-595
34. Stathatos N., Levetan C., Burman K.D., and Wartofsky L. The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab 15 (2001) 465-478
35. Chambers J.M., Cleveland W.S., Kleiner B., and Tukey PA. Graphical methods for data analysis (1983), Wadsworth & Brooks/Cole